Article info
PDFPostScript
Letter
Integrated prognostic and histogenomic justification of stage-directed therapy for single large hepatocellular carcinoma: a Korean nationwide registry study
- Correspondence to Professor Jihyun An, Department of Gastroenterology, Hanyang University, Guri, Korea (the Republic of); starlit1{at}naver.com; Professor Ju Hyun Shim, Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, The Republic of Korea; s5854{at}amc.seoul.kr
Citation
Integrated prognostic and histogenomic justification of stage-directed therapy for single large hepatocellular carcinoma: a Korean nationwide registry study
Publication history
- Received August 10, 2021
- Accepted August 28, 2021
- First published September 7, 2021.
Online issue publication
October 18, 2023
Article Versions
- Previous version (5 May 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.